SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-06-009130
Filing Date
2006-02-09
Accepted
2006-02-09 16:48:56
Documents
1
Period of Report
2006-02-09

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION bsf17129_bsf1ms.html 3  
1 MAIN DOCUMENT DESCRIPTION bsf17129_bsf1ms.xml 3 11103
  Complete submission text file 0001209191-06-009130.txt   12796
Mailing Address
Business Address 15 SKYLINE DRIVE HAWTHORNE NY 10532 914-347-4300
ACORDA THERAPEUTICS INC (Issuer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116
Business Address 6174259200
STEINMETZ MICHAEL (Reporting) CIK: 0001166285 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50513 | Film No.: 06593638